fda-inspection-records

FDA inspections of firms in Raritan, NJ

11 firms in Raritan were inspected by the FDA between fiscal years 2009 and 2026. Their most serious classification on file: 5 NAI, 6 VAI, 0 OAI. Main product types: Drugs (6), Biologics (4), Devices (3).

FirmProduct typesInspectionsLatest inspection483 observations posted
Ajanta Pharma USA Inc.
FEI 3005908576
Drugs1May 8, 2013 · NAI—
Arctic Glacier USA, Inc.
FEI 3005019837
Food/Cosmetics1Mar 19, 2013 · NAI—
Ethicon, Inc.
FEI 3017102971
Devices1Aug 15, 2025 · NAI—
Janssen Diagnostics, LLC
FEI 3004619490
Devices1Dec 17, 2008 · VAI1
Janssen Pharmaceuticals Inc.
FEI 2211100
Biologics; Drugs9Dec 14, 2023 · VAI4
Janssen Research & Development
FEI 3009637192
Drugs3Mar 1, 2023 · NAI2
Janssen Supply Chain, LLC
FEI 3006973549
Drugs4Nov 20, 2014 · NAI1
Johnson & Johnson Pharmaceutical Research & Development, LLC
FEI 3006192174
Drugs6Jun 30, 2011 · NAI1
Laboratory Corporation of America Holdings
FEI 1000526836
Biologics2May 23, 2025 · NAI—
New York Blood Center Inc. Ortho Diagnostics Donor Center
FEI 1000142917
Biologics5Oct 29, 2018 · NAI—
Ortho-Clinical Diagnostics, Inc.
FEI 2250051
Biologics; Devices; Drugs10Jun 13, 2025 · NAI4

Alphabetical order — this site ranks no firm. Inspections from fiscal year 2009 to 2026; the classification is the FDA's (NAI no action indicated, VAI voluntary action indicated, OAI official action indicated). Select a firm for every inspection, the posted Form 483 observations and any compliance action. How to read this.